86. Pulmonary arterial hypertension Clinical trials / Disease details

Clinical trials : 1,205 / Drugs : 684 - (DrugBank : 124) / Drug target genes : 100 - Drug target pathways : 193

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02304198 (ClinicalTrials.gov)	April 2014	26/11/2014	Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH	A Single-arm, Open-label, Extension Study to Evaluate the Long-term Safety of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)	Pulmonary Arterial Hypertension	Drug: Udenafil	Dong-A ST Co., Ltd.	NULL	Completed	18 Years	N/A	Both	59	Phase 2/Phase 3	Korea, Republic of
2	NCT01553721 (ClinicalTrials.gov)	August 2011	1/1/2012	Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)	A Placebo-controlled, Double-blind, Phase II Clinical Study to Evaluate the Efficacy and Safety of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)	Pulmonary Arterial Hypertension	Drug: udenafil;Drug: placebo	Dong-A ST Co., Ltd.	NULL	Completed	18 Years	N/A	Both	63	Phase 2	Korea, Republic of